Señales en vivo de 000403.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 03:04):

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China...

Stats
Volumen de hoy	3.46M
Volumen promedio	5.61M
Capitalización de mercado	21.75B
EPS	CNY0.250 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.79
ATR14	CNY0.0320 (0.11%)

Volumen Correlación

Largo: 0.07 (neutral)

Corto: 0.85 (strong)

Signal:(63.153) Same movement expected

Pacific Shuanglin Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pacific Shuanglin Correlación - Moneda/Commodity

0.43
( neutral )

0.37
( neutral )

0.00
( neutral )

0.69
( moderate )

0.16
( neutral )

-0.22
( neutral )

Pacific Shuanglin Finanzas

Annual	2023
Ingresos:	CNY2.33B
Beneficio Bruto:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2023
Ingresos:	CNY2.33B
Beneficio Bruto:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2022
Ingresos:	CNY2.41B
Beneficio Bruto:	CNY1.25B (52.13 %)
EPS:	CNY0.800

FY	2021
Ingresos:	CNY1.97B
Beneficio Bruto:	CNY908.43M (46.07 %)
EPS:	CNY0.554

Financial Reports:

No articles found.

Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.